Lantheus Holdings, Inc. Payments of Debt Issuance Costs
Lantheus Holdings, Inc. (LNTH) reported Payments of Debt Issuance Costs of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2025-02-26
- Lantheus Holdings, Inc. payments of debt issuance costs for the quarter ending 2021-12-31 was $0.00.
- Lantheus Holdings, Inc. payments of debt issuance costs for the quarter ending 2021-09-30 was $0.00.
- Lantheus Holdings, Inc. payments of debt issuance costs for the quarter ending 2020-12-31 was -$1.22M, a 645.98% decline year-over-year.
- Lantheus Holdings, Inc. payments of debt issuance costs for the quarter ending 2020-09-30 was -$2.00K.
- Lantheus Holdings, Inc. payments of debt issuance costs for fiscal 2024 was $0.00.
- Lantheus Holdings, Inc. payments of debt issuance costs for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Lantheus Holdings, Inc. payments of debt issuance costs for fiscal 2022 was $95.00K.
- Lantheus Holdings, Inc. payments of debt issuance costs for fiscal 2021 was $0.00.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month | Payments of Debt Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-26 | ||||
| 2023-12-31 | $0.00 10-K · filed 2025-02-26 | ||||
| 2022-12-31 | $95.00K 10-K · filed 2025-02-26 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | $0.00 10-K · filed 2024-02-22 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | |||
| 2021-06-30 | $0.00 10-Q · filed 2021-07-28 | ||||
| 2020-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$1.23M derived: sum of 2 quarters · filed 2023-02-23 | $0.00 10-K · filed 2023-02-23 | $1.22M 10-K · filed 2021-02-25 | |
| 2020-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.22M 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | $1.23M 10-Q · filed 2021-07-28 | ||||
| 2019-12-31 | $224.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $224.00K derived: sum of 2 quarters · filed 2022-02-24 | $2.26M 10-K · filed 2022-02-24 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.03M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | $2.03M 10-Q · filed 2020-07-31 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | $0.00 derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $0.00 10-Q · filed 2019-07-25 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $0.00 derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-02 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $0.00 derived: sum of 3 quarters · filed 2020-02-25 | $357.00K derived: sum of 4 quarters · filed 2020-02-25 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | $357.00K derived: sum of 3 quarters · filed 2020-02-25 | $1.58M 10-K · filed 2020-02-25 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $357.00K derived: sum of 2 quarters · filed 2018-10-30 | $1.58M 10-Q · filed 2018-10-30 | $1.58M derived: sum of 4 quarters · filed 2019-02-20 | |
| 2017-06-30 | $357.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $1.58M 10-Q · filed 2018-08-01 | $1.58M derived: sum of 3 quarters · filed 2019-02-20 | $1.58M derived: sum of 4 quarters · filed 2019-02-20 | |
| 2017-03-31 | $1.22M 10-Q · filed 2018-05-02 | $1.22M derived: sum of 2 quarters · filed 2019-02-20 | $1.22M derived: sum of 3 quarters · filed 2019-02-20 | $1.23M derived: sum of 4 quarters · filed 2019-02-20 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $0.00 derived: sum of 2 quarters · filed 2019-02-20 | $11.00K derived: sum of 3 quarters · filed 2019-02-20 | $11.00K 10-K · filed 2019-02-20 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $11.00K derived: sum of 2 quarters · filed 2017-11-02 | $11.00K 10-Q · filed 2017-11-02 | $18.00K derived: sum of 4 quarters · filed 2018-02-26 | |
| 2016-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $11.00K 10-Q · filed 2016-08-04 | $18.00K derived: sum of 3 quarters · filed 2018-02-26 | $1.00M derived: sum of 4 quarters · filed 2018-02-26 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-02 | $7.00K derived: sum of 2 quarters · filed 2018-02-26 | $989.00K derived: sum of 3 quarters · filed 2018-02-26 | ||
| 2015-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $989.00K derived: sum of 2 quarters · filed 2018-02-26 | $6.30M 10-K · filed 2018-02-26 | ||
| 2015-09-30 | $982.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $6.30M 10-Q · filed 2016-11-01 | |||
| 2015-06-30 | $5.32M 10-Q · filed 2016-08-04 | ||||
| 2014-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $91.00K derived: sum of 2 quarters · filed 2017-02-23 | $175.00K 10-K · filed 2017-02-23 | ||
| 2014-09-30 | $55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $139.00K 10-Q · filed 2015-11-04 | |||
| 2014-06-30 | $84.00K 10-Q · filed 2015-08-05 | ||||
| 2013-12-31 | $1.25M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |